ReGelTec: Percutaneous Treatment for Degenerative Disc Disease
Bill Niland, CEO
Discogenic pain is considered a normal part of aging. As the spinal disc wears down with age, disc fluid starts to dry out and no longer cushions the bones, leaving people to endure chronic pain. While conservative treatment and opioid injections offer temporary pain relief, there is no effective, long-term treatment for degenerative disc disease. With the ineffectiveness of regenerative stem cell therapy for discogenic pain in the elderly, an increasing number of people with chronic lower back pain are left with no option but to opt for complicated, high-risk spinal surgeries.ReGelTec, a clinical-stage medical device company, breaks through the conventional way of treating degenerative disc disease with its novel proprietary product, HYDRAFIL.
“According to two years of patient data, we successfully treated moderate to severe conditions of degeneration of the disc using a simple injection that helps patients get back to their normal lifestyle,” says Bill Niland, CEO of ReGelTec.
Read the full article at: www.medicaltechoutlook.com
